Sample and treatment | Raw reads | Clean reads (%) | GC % | Q20 | Q30 |
---|---|---|---|---|---|
CKL1 | 44,099,018 | 43,547,360(98.75%) | 44.05% | 96.28% | 90.97% |
CKL2 | 43,366,334 | 42,740,292(98.56%) | 44.16% | 96.30% | 91.09% |
CKL3 | 46,852,726 | 46,505,542(99.26%) | 43.92% | 96.08% | 90.59% |
Average (CKL) | 44,772,693 | 44,264,398(98.86%) | 44.04% | 96.22% | 90.88% |
NNL1 | 48,563,670 | 48,284,164(99.42%) | 43.18% | 95.78% | 90.06% |
NNL2 | 45,788,340 | 45,540,402(99.46%) | 43.17% | 95.99% | 90.44% |
NNL3 | 38,701,550 | 38,451,384(99.35%) | 43.23% | 96.19% | 90.81% |
Average (NNL) | 44,351,187 | 44,091,983(99.42%) | 43.19% | 95.99% | 90.44% |
CKR1 | 44,600,070 | 44,324,964(99.38%) | 43.72% | 95.88% | 90.28% |
CKR2 | 42,203,314 | 41,834,642(99.13%) | 43.72% | 95.77% | 90.02% |
CKR3 | 53,027,440 | 52,667,716(99.32%) | 42.97% | 96.19% | 91.01% |
Average (CKR) | 46,610,275 | 46,275,774(99.28%) | 43.47% | 95.95% | 90.44% |
NNR1 | 45,849,948 | 45,485,956(99.30%) | 43.26% | 96.13% | 90.73% |
NNR2 | 43,861,456 | 43,555,094(99.30%) | 43.08% | 95.87% | 90.24% |
NNR3 | 42,040,232 | 41,564,386(98.87%) | 43.32% | 95.86% | 90.21% |
Average (NNR) | 43,917,212 | 43,535,145(99.13%) | 43.22% | 95.95% | 90.39% |